Erythromycin Ethylsuccinate

   
Google
 
Web NewDrugInformation.com

Erythromycin Ethylsuccinate


Drug - Erythromycin Ethylsuccinate
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Erythromycin Ethylsuccinate
Multiple ingredients are in alphabetical order.

Strength - EQ 400MG BASE
The potency of the active ingredient(s), Erythromycin Ethylsuccinate. May repeat for multiple part products.

Applicant - BARR
The firm name holding legal responsibility for Erythromycin Ethylsuccinate. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 062256
The FDA assigned number to Erythromycin Ethylsuccinate. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Erythromycin Ethylsuccinate. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Erythromycin Ethylsuccinate was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Erythromycin Ethylsuccinate. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Erythromycin Ethylsuccinate is in. Format is RX, OTC, DISCN.

Applicant Full Name - Barr Laboratories Inc
The full name of the firm holding legal responsibility for the new application of Erythromycin Ethylsuccinate.

Erythromycin Ethylsuccinate